S&P 500
(0.27%) 5 475.09 points
Dow Jones
(0.13%) 39 170 points
Nasdaq
(0.83%) 17 879 points
Oil
(0.12%) $83.48
Gas
(-0.04%) $2.48
Gold
(0.14%) $2 342.20
Silver
(0.50%) $29.76
Platinum
(0.45%) $993.10
USD/EUR
(0.04%) $0.931
USD/NOK
(0.15%) $10.66
USD/GBP
(0.02%) $0.791
USD/RUB
(0.01%) $86.76

Realtime updates for Acrivon Therapeutics, [ACRV]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Last Updated1 Jul 2024 @ 16:00

1.03% $ 5.86

Live Chart Being Loaded With Signals

Commentary (1 Jul 2024 @ 16:00):
Our systems believe the stock currently is undervalued by 0.18% compare to its pairs and should correct upwards.

Acrivon Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing oncology medicines for the patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform...

Stats
Today's Volume 230 871
Average Volume 802 196
Market Cap 180.94M
EPS $-0.730 ( Q1 | 2024-05-14 )
Next earnings date ( $-0.590 ) 2024-08-09
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -2.03
(Sector) 42.63
(Industry) 24.32
ATR14 $0.0260 (0.44%)
AADI -2.74%
ABCL -6.08%
ABCM 0.04%
ABEO -0.94%
ABIO -0.78%
ABOS -1.45%
ABSI -2.27%
ABUS 0.97%
ABVX 2.57%
ACAD -1.29%
ACER -17.95%
ACET -4.96%
ACGN 1.29%
ACHL -1.60%
ACHV 1.70%
ACIU -0.25%
ACLX -2.88%
ACRV 1.03%
ACST -2.34%
ACXP -4.89%
ADAG -0.33%
ADAP 7.70%
ADGI 0.87%
ADIL -5.22%
ADMA 3.31%
ADPT -0.55%
ADTX 14.49%
ADVM 1.60%
ADXN -12.26%
AEON -0.95%
AEZS 3.07%
AFMD -0.73%
AGEN -0.36%
AGIO 0.60%
AGLE 6.66%
AGTC 0.00%
AIKI 0.85%
AIMDW -13.88%
AKBA -2.51%
AKRO -1.28%
AKTX 15.23%
AKUS 0.00%
ALBO 0.00%
ALDX -1.81%
ALEC -2.64%
ALGS 5.43%
ALKS 1.20%
ALLK -12.02%
ALLO 0.00%
ALLR 6.44%
ALNA 3.16%
ALNY 0.13%
ALPN 0.02%
ALPX 0.00%
ALRN 1.08%
ALT 8.27%
ALVR 0.93%
ALXN 0.00%
ALXO -0.66%
ALZN 0.91%
AMRN -0.29%
AMTI -3.13%
ANAB -1.80%
ANEB -1.83%
ANGN 0.00%
ANIX 0.45%
ANL -6.05%
ANNX 3.06%
ANPC -3.15%
APGE -1.96%
APGN 8.48%
APGNW 30.65%
APLM 0.96%
APLS -5.40%
APLT -1.28%
APM -7.51%
APOP 0.38%
APRE -0.98%
APTO -1.51%
APTX 3.17%
APVO 9.15%
ARAV -13.39%
ARCT -2.83%
ARDS 19.76%
ARDX 2.16%
ARGX 0.97%
ARNA 0.00%
ARPO -0.90%
ARQT 2.80%
ARTL -3.57%
ARTLW 0.00%
ARVN -2.40%
ARWR 0.23%
ASLN 0.00%
ASMB -3.50%
ASND -1.76%
ATAI 1.50%
ATHA -5.28%
ATHE 0.00%
ATHX -33.50%
ATNF -7.98%
ATOS 0.84%
ATRA -1.65%
ATXI -2.86%
ATXS 1.65%
AUPH -3.85%
AURA -2.51%
AUTL -0.29%
AVBP -2.16%
AVEO 0.00%
AVIR 1.81%
AVRO -1.41%
AVTE 2.41%
AVTX 1.12%
AVXL -2.61%
AXLA 0.00%
AXSM 0.66%
AYLA 0.00%
AZRX 2.07%
BBI 2.17%
BBIO -0.51%
BCAB -1.46%
BCDA 0.67%
BCDAW 0.00%
BCEL 0.00%
BCLI 5.47%
BCRX 7.93%
BCTX -4.39%
BCTXW 17.17%
BCYC 0.25%
BDRX -0.23%
BDTX 0.86%
BEAM -1.62%
BFRA -2.91%
BGNE 1.56%
BIOR -4.56%
BIVI 4.00%
BLCM -6.68%
BLI -5.88%
BLPH -1.93%
BLRX -1.06%
BLTE 0.31%
BLU 0.03%
BLUE -0.90%
BMEA -1.78%
BMRN -0.24%
BNOX -10.04%
BNTC 3.92%
BNTX -1.90%
BOLD 8.27%
BOLT -2.41%
BPMC 1.30%
BPTH -3.00%
BPTS -13.47%
BRNS 2.14%
BRTX -2.46%
BTAI -8.59%
BTTX -15.97%
BTX 0.05%
BVXV 0.74%
BXRX 7.39%
BYSI 2.92%
CABA 4.41%
CADL 1.61%
CALA 0.00%
CALC 7.32%
CALT -0.62%
CAPR 1.47%
CARA 1.94%
CARM 9.87%
CASI -1.82%
CATB -6.97%
CBAY 0.03%
CBIO -2.65%
CBLI -7.31%
CBUS -5.89%
CCCC 4.98%
CCXI 0.00%
CDAK 0.00%
CDIO -1.82%
CDIOW 6.00%
CDMO -0.28%
CDMOP 0.04%
CDT -6.12%
CDTTW 72.08%
CDTX 0.84%
CDXC -1.47%
CDXS -3.55%
CELC 1.59%
CELU 1.92%
CELUW 1.32%
CERC -1.68%
CERE 1.13%
CERO -8.16%
CEROW 43.57%
CFRX -27.95%
CGEM -4.07%
CGEN 4.17%
CGON 0.48%
CGTX 0.60%
CHMA -6.00%
CHRS -6.94%
CINC 0.00%
CING 7.50%
CINGW 4.85%
CKPT -4.65%
CLBS -16.75%
CLDX 5.35%
CLGN 1.00%
CLLS 3.48%
CLNN 0.22%
CLNNW 44.05%
CLRB 2.00%
CLSD -4.62%
CLSN -0.68%
CLVS 0.00%
CMMB 5.00%
CMND -1.19%
CMPI 0.00%
CMPX -5.45%
CMRA 0.00%
CMRAW 33.33%
CMRX -0.80%
CNCE 0.00%
CNSP -10.13%
CNST 0.00%
CNTA -2.55%
CNTB -5.26%
CNTX -9.73%
COCP 3.00%
COEPW 0.00%
COGT 6.05%
CORT 0.55%
COYA 0.66%
CPRX 1.81%
CRBP 9.17%
CRBU -3.05%
CRDF -7.66%
CRGX -2.56%
CRIS -7.54%
CRNX 2.86%
CRSP -0.11%
CRTX 2.63%
CRVO -5.84%
CRVS 1.65%
CSBR -4.26%
CTCX 23.31%
CTIC 0.06%
CTMX 9.02%
CTNM 19.25%
CTXR -6.92%
CUE -17.74%
CVAC -2.06%
CVKD -1.15%
CWBR 0.00%
CYAD -12.96%
CYCC 0.00%
CYCCP -11.68%
CYCN 0.88%
CYT -2.27%
CYTK 0.96%
CYTO 9.91%
DARE -6.03%
DAWN -1.45%
DBTX -0.81%
DBVT 2.20%
DFFN 10.28%
DICE 0.06%
DMAC 0.00%
DNLI -5.21%
DNTH 11.55%
DOMH 4.81%
DRMA -5.37%
DRMAW 7.69%
DRNA 0.00%
DRTS 0.79%
DRTSW 19.05%
DRUG -2.77%
DSGN -2.99%
DTIL 1.64%
DYAI 3.38%
EARS -1.77%
EDIT -1.28%
EDSA 2.09%
EFTR -8.00%
EFTRW -41.67%
EIGR -9.21%
ELAB 0.07%
ELDN -4.92%
ELEV 5.93%
ELOX 1.45%
ELTX -8.03%
ELVN -2.87%
ELYM -0.84%
ENGN -4.03%
ENGNW -2.88%
ENLV -2.82%
ENOB 1.79%
ENSC -1.23%
ENTA 0.77%
ENTO -11.11%
ENTX -4.35%
ENVB -5.90%
EPIX -2.66%
EPRX 2.38%
EPZM 0.00%
EQ -2.21%
EQRX -2.09%
EQRXW 0.00%
ERAS 3.39%
ERNA 4.14%
ERYP 1.30%
ESLA 4.76%
ESLAW 0.00%
ETNB -3.12%
ETON 3.34%
ETTX 0.00%
EVAX 0.70%
EVGN -0.91%
EVLO 39 899.32%
EWTX 7.61%
EXAI 0.98%
EXEL -0.98%
EYEG -0.51%
EYEN 14.27%
EYPT -4.48%
FATE -0.61%
FBIO -1.17%
FBIOP 0.70%
FBLG -19.84%
FBRX 1.68%
FDMT 1.67%
FENC 2.62%
FGEN -13.69%
FHTX 1.57%
FIXX 0.77%
FMTX 0.00%
FNCH -10.95%
FOLD -1.21%
FREQ 4.76%
FRLN 0.15%
FRTX -4.21%
FSTX 0.00%
FTRE 2.23%
FULC 1.77%
FUSN 0.00%
FWBI 4.59%
FWP 0.00%
GALT 3.98%
GANX -12.50%
GBIO -8.87%
GBT 0.01%
GDTC -0.99%
GERN 2.36%
GHRS 0.77%
GLMD -1.01%
GLPG 0.93%
GLSI -2.84%
GLTO -1.73%
GLUE 5.35%
GLYC 5.15%
GMAB -1.11%
GMDA -18.25%
GMTX 0.00%
GNCA -85.71%
GNFT 10.80%
GNLX -5.64%
GNPX 2.39%
GNTA -0.87%
GOSS 5.18%
GOVX 2.98%
GOVXW -10.37%
GPCR 1.86%
GRAY -10.80%
GRCL 0.05%
GRNA -0.03%
GRNAW 8.91%
GRPH -2.75%
GRTS -6.13%
GRTX -8.63%
GTHX 8.33%
GUTS 4.45%
GXGXW 41.67%
GYRE 0.92%
HALO -0.65%
HARP 0.09%
HCWB 0.46%
HEPA -0.93%
HGEN -84.62%
HILS 5.66%
HLVX -0.28%
HOOK 6.17%
HOTH -1.12%
HOWL -3.69%
HRMY 0.83%
HRTX -0.86%
HSTO 0.00%
HUMA 11.88%
HUMAW 22.30%
IBRX -0.79%
ICCC -8.04%
ICPT 0.21%
ICU 23.06%
ICUCW 13.26%
ICVX -0.91%
IDRA -23.04%
IDYA 2.31%
IFRX -1.72%
IGMS -1.16%
IKNA 0.00%
IKT -5.34%
IMAB -2.99%
IMCR 7.49%
IMGN 0.02%
IMGO 0.00%
IMMP 0.00%
IMMX 7.07%
IMNM 0.83%
IMNN 8.62%
IMPL -27.27%
IMRA 15.96%
IMRN -9.26%
IMRX -8.59%
IMTX 3.27%
IMTXW 27.41%
IMUX 0.90%
IMV 0.00%
IMVT 4.20%
INAB -3.95%
INBX -3.03%
INCY 0.41%
INDP 4.25%
INFI -52.38%
INKT -3.51%
INM -5.24%
INMB -4.54%
INO 6.56%
INSM -0.99%
INTS 0.41%
INVA 0.61%
INZY -1.12%
IOBT -4.27%
IONS -1.15%
IOVA 0.50%
IPA -3.71%
IPHA 7.22%
IPSC -5.49%
IRON 3.11%
ISEE 0.38%
ITOS 1.15%
ITRM -5.60%
IVA -1.19%
IVVD 9.09%
JAGX -2.79%
JANX -0.41%
JAZZ -0.24%
JNCE 0.00%
JSPR 1.94%
JSPRW 5.15%
JUNS 0.00%
JUNSW 0.00%
KA 4.20%
KALV 0.93%
KDNY 0.22%
KMPH -0.34%
KNSA -3.59%
KNTE -0.38%
KOD 0.85%
KPRX 3.57%
KPTI -6.01%
KRBP -1.83%
KRON -9.68%
KROS -4.22%
KRRO -0.06%
KRTX 0.03%
KRYS -0.75%
KTRA 10.14%
KTTA 0.38%
KTTAW 1.83%
KURA 2.96%
KYMR 3.69%
KYTX 4.13%
KZIA -4.91%
KZR -2.73%
LABP 0.57%
LBPH 14.39%
LBPS 0.00%
LBPSW 14.81%
LEGN 3.91%
LENZ 2.31%
LEXX -0.72%
LEXXW 23.90%
LGND 0.70%
LGNDV 0.00%
LGVN -2.48%
LIAN -8.28%
LIFE 2.70%
LIPO -3.41%
LIXT -0.38%
LIXTW -3.71%
LJPC -0.32%
LMNL 0.12%
LOGC -3.15%
LPCN -6.31%
LPTX -4.59%
LQDA 0.33%
LRMR 13.66%
LSTA 2.31%
LTRN -3.21%
LUMO -2.46%
LVTX 3.89%
LXEO -2.68%
LXRX -0.30%
LYEL 8.97%
LYRA 7.30%
MACK 0.10%
MBIO 2.41%
MBRX -1.15%
MCRB -0.25%
MDGL -0.30%
MDNA -13.16%
MDWD -0.84%
MDXG -3.32%
MEIP -2.06%
MESO -0.44%
MGNX 1.18%
MGTA -7.74%
MGTX -2.61%
MGX 8.33%
MIRM -0.09%
MIRO 0.59%
MIST 0.75%
MITO 0.00%
MLEC -0.88%
MLECW -31.50%
MLND -5.36%
MLTX -4.94%
MLYS 4.02%
MNKD -2.49%
MNMD -1.94%
MNOV 0.00%
MNPR -0.88%
MOLN 2.80%
MOR -0.22%
MORF -4.46%
MREO 0.83%
MRKR -0.74%
MRNA -2.36%
MRNS 9.40%
MRSN -1.99%
MRTX -0.17%
MRUS -7.98%
MRVI -3.07%
MTCR -1.29%
MTEM 2.61%
MTP -18.50%
MURA -0.96%
MYMD 0.00%
NAMS 7.13%
NAMSW -4.76%
NAUT -2.99%
NBRV 0.71%
NBSE -1.56%
NBTX 7.00%
NCNA 7.36%
NERV -0.86%
NEXI -6.90%
NGM -1.28%
NGNE 11.62%
NKGN 0.00%
NKGNW -12.00%
NKTR -1.61%
NKTX -1.02%
NLSP -9.50%
NLSPW 26.58%
NMRA 1.12%
NMTR -42.97%
NOVN -24.84%
NRBO -6.20%
NRIX 0.19%
NRSN -3.57%
NRSNW -2.91%
NRXP 5.74%
NRXPW 41.43%
NRXS 1.44%
NTBL -6.12%
NTEC -12.45%
NTHI 0.00%
NTLA 0.40%
NTRBW 74.65%
NUVL -0.46%
NVAX 0.55%
NVCT -2.37%
NVIV -34.28%
NXTC -5.66%
NYMX -0.05%
OABI -0.27%
OABIW -9.28%
OBIO -12.64%
OBSV 0.00%
OCEA -3.28%
OCGN 4.84%
OCS -0.50%
OCUL -2.63%
OCUP 3.92%
ODT -4.27%
OKYO 1.64%
OLMA 2.96%
OMER -2.71%
OMGA 8.70%
ONCO -6.10%
ONCR -3.08%
ONCS 31.87%
ONCT -7.70%
ONCY 0.53%
ONTX -0.47%
ONVO -0.34%
OPNT 0.00%
OPT -0.99%
ORGS 8.13%
ORIC 8.06%
ORMP -0.39%
ORPH 0.00%
ORTX 0.30%
OSMT -1.77%
OTIC -92.64%
OTLK 0.41%
OVID 12.09%
OYST 0.00%
PALI -5.29%
PASG 11.43%
PBLA -10.00%
PBM 6.33%
PBYI 0.61%
PCSA -7.11%
PCVX 1.89%
PDSB 3.41%
PEPG 12.22%
PGEN -1.90%
PHAR -4.62%
PHAS 0.00%
PHAT 4.95%
PHIO -3.88%
PHIOW 36.47%
PHVS -0.59%
PHXM -5.20%
PIRS -1.82%
PKBO 0.00%
PKBOW 999 900.00%
PLRX 1.02%
PLUR -0.43%
PMN 6.67%
PMVP -2.47%
PNT 0.16%
PPBT -13.47%
PRAX -0.41%
PRDS 0.93%
PRLD -1.05%
PROG -3.47%
PROK 1.63%
PRQR -0.60%
PRTA -0.78%
PRTC 3.68%
PRTG -7.63%
PRTK 1.83%
PRVB 0.00%
PSTI -2.91%
PSTV 2.04%
PSTX 3.08%
PTCT 1.93%
PTE -0.82%
PTGX 1.59%
PTIXW -48.41%
PULM 1.55%
PXMD -1.27%
PYPD -0.24%
PYXS -3.32%
QLGN -3.77%
QNCX -3.33%
QNRX 1.75%
QSI -11.01%
QSIAW 4.08%
QTTB 5.74%
QURE -0.78%
RAIN -1.63%
RANI 0.53%
RAPT -5.57%
RARE 0.05%
RCKT -4.04%
REGN 0.57%
RENB -10.86%
REPL 4.00%
RETA 0.02%
REUN -0.89%
REVB -1.58%
REVBU 3.46%
REVBW 0.00%
RGLS 6.44%
RGNX -5.38%
RIGL 2.31%
RLAY -1.84%
RLMD 2.33%
RLYB 1.49%
RNA 1.05%
RNAC -10.14%
RNAZ -4.54%
RNXT 1.77%
ROIV 2.46%
ROIVW 4.56%
RPHM 2.65%
RPRX -0.68%
RPTX 0.91%
RUBY 2.70%
RVLP -32.05%
RVMD 0.00%
RVMDW -1.40%
RVNC 0.00%
RVPH -7.03%
RVPHW 4.88%
RXDX 0.09%
RXRX -0.53%
RYTM 3.92%
RYZB 0.02%
RZLT 0.23%
SABS -1.94%
SABSW 54.57%
SAGE 1.57%
SANA 0.18%
SAVA -1.70%
SAVAW 0.00%
SBBP 1.52%
SBTX 1.03%
SCNI 3.16%
SCPH -0.69%
SCPS 0.00%
SEEL 3.69%
SEER 0.60%
SELB -8.00%
SESN 7.29%
SGEN -0.07%
SGMO -7.90%
SGMT -7.60%
SGTX -2.56%
SIOX 22.63%
SLDB 10.58%
SLGL -4.21%
SLN -1.37%
SLNO 3.65%
SLRX -7.92%
SLS -0.84%
SMMT 4.36%
SNDX 4.87%
SNGX -4.26%
SNPX 1.97%
SONN -0.80%
SPPI -0.49%
SPRB 2.55%
SPRC -5.98%
SPRO -1.54%
SRNE -20.00%
SRPT -0.79%
SRRA 0.00%
SRRK -2.40%
SRZN -2.28%
STAB 0.00%
STOK 2.66%
STRO 4.10%
STSA 0.00%
STTK 3.37%
SURF -0.93%
SVRA 15.14%
SWTX 2.28%
SYBX -0.67%
SYRS -4.46%
TALS -0.73%
TARA 0.48%
TARS 3.90%
TBPH 0.47%
TCBP 1.76%
TCDA 0.00%
TCON -30.63%
TCRR 0.00%
TCRT -6.87%
TCRX 1.37%
TECH -0.06%
TENX -1.32%
TERN 0.59%
TFFP 7.23%
TGTX 2.02%
THRX 0.12%
TIL 0.10%
TLC 0.00%
TLSA -3.63%
TNGX 4.90%
TNXP 4.96%
TNYA 8.71%
TPST -2.28%
TRDA 0.49%
TRVI -3.02%
TRVN -3.81%
TSHA 0.89%
TSVT 5.19%
TTNP -0.18%
TVTX 0.73%
TYRA 8.07%
UBX -1.48%
UNCY 7.76%
URGN -1.79%
UTHR 0.14%
VACC 11.36%
VALN -3.27%
VAXX 20.24%
VBIV 4.85%
VBLT -8.77%
VCEL -1.85%
VCNX -0.15%
VCYT -1.57%
VERA 0.30%
VERU 4.45%
VERV 2.05%
VIGL 9.25%
VINC -6.26%
VIR 2.25%
VIRI 3.26%
VIRX -6.20%
VKTX 4.36%
VLON -13.04%
VNDA -1.24%
VOR -1.07%
VRCA 9.05%
VRDN 1.54%
VRNA 7.26%
VRPX -1.59%
VRTX 0.54%
VSTM 9.06%
VTGN 2.59%
VTVT -0.42%
VTYX -2.16%
VXRT 3.19%
VYGR -0.63%
VYNE -2.54%
VYNT 7.78%
WINT 0.00%
WVE 4.91%
XBIO -0.48%
XBIT 7.98%
XCUR -3.93%
XENE -3.33%
XERS -3.56%
XFOR 1.62%
XLO -2.49%
XLRN 0.00%
XNCR 0.48%
XOMA 5.11%
XOMAO 0.20%
XOMAP 1.98%
XRTX -1.06%
YMAB -2.07%
ZGNX 0.00%
ZIOP -0.88%
ZLAB -0.23%
ZNTL 2.45%
ZSAN 0.00%
Insider Trading
Date Person Action Amount type
2024-06-20 Ra Capital Management, L.p. Buy 20 275 Stock Option (Right to Buy)
2024-06-20 Tomsicek Michael John Buy 20 275 Stock Option (Right to Buy)
2024-06-20 Shacham Sharon Buy 20 275 Stock Option (Right to Buy)
2024-06-20 Dirocco Derek Buy 20 275 Stock Option (Right to Buy)
2024-06-20 Baum Charles M Buy 20 275 Stock Option (Right to Buy)
INSIDER POWER
30.97
Last 74 transactions
Buy: 13 136 701 | Sell: 16 713 897
Correlation (AI algo v.1.1b): Undervalued: 0.18% $5.87 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Volume Correlation

Long: -0.42 (neutral)
Short: 0.23 (neutral)
Signal:(39.781) Neutral

Acrivon Therapeutics, Correlation

10 Most Positive Correlations
INDH0.92
JVSAU0.873
NEWZ0.862
ADTHW0.851
CCSB0.831
HYMCL0.809
10 Most Negative Correlations
OZEM-1
ATPC-0.828
PFLEX-0.827
BOCNW-0.826
CVKD-0.826
AGNCL-0.818
HDL-0.818
SIYYX-0.816
LESL-0.813
OMIC-0.813

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Acrivon Therapeutics, Correlation - Currency/Commodity

The country flag 0.15
( neutral )
The country flag -0.10
( neutral )
The country flag 0.00
( neutral )
The country flag 0.57
( weak )
The country flag -0.05
( neutral )
The country flag -0.30
( neutral )

Acrivon Therapeutics, Financials

Annual 2023
Revenue: $0
Gross Profit: $-536 000 (0.00 %)
EPS: $-2.74
FY 2023
Revenue: $0
Gross Profit: $-536 000 (0.00 %)
EPS: $-2.74
FY 2022
Revenue: $0
Gross Profit: $-1.10M (0.00 %)
EPS: $-1.350
FY 2021
Revenue: $0.00
Gross Profit: $0.00 (0.00 %)
EPS: $-1.260

Financial Reports:

No articles found.

Acrivon Therapeutics, Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Acrivon Therapeutics,

Acrivon Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing oncology medicines for the patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company\'s Acrivon Predictive Precision Proteomics, a precision medicine platform enables the creation of drug specific proprietary OncoSignature companion diagnostics that are used to identify the patients to benefit from its drug candidates. Its lead clinical candidate is ACR-368, a selective small molecule inhibitor targeting CHK1 and CHK2, which is in a potentially registrational Phase 2 trial across various tumor types, including platinum-resistant ovarian, endometrial, and bladder cancer. The company is also developing its preclinical stage pipeline programs targeting critical nodes in the DNA damage response and cell cycle regulation pathways, such as WEE1, a protein kinase and PKMYT1, a protein serine/threonine kinase. The company was incorporated in 2018 and is based in Watertown, Massachusetts.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Total Execution Time: 2.5300300121307 seconds
Number of API calls: 3
Number of DB calls: 9